首页> 外文期刊>Stem cell research >Generation of GZKHQi001-A and GZWWTi001-A, two induced pluripotent stem cell lines derived from peripheral blood mononuclear cells of Duchenne muscular dystrophy patients - ScienceDirect
【24h】

Generation of GZKHQi001-A and GZWWTi001-A, two induced pluripotent stem cell lines derived from peripheral blood mononuclear cells of Duchenne muscular dystrophy patients - ScienceDirect

机译:GZKHQi001-A和GZWWTi001-A的产生,这两种诱导的多能干细胞系来源于杜兴氏肌营养不良患者的外周血单核细胞-ScienceDirect

获取原文
           

摘要

Duchenne muscular dystrophy (DMD) is an X-linked disease caused by mutations in the DMD gene, which spans ~?2.4?Mb of genomic sequence at locus Xp21. This mutation results in the loss of the protein dystrophin. DMD patients die in their second or third decade due to either respiratory failure or cardiomyopathy, as the absence of dystrophin leads to myofiber membrane fragility and necrosis, eventually resulting in muscle atrophy and contractures. Currently, there is no effective treatment for DMD, therefore induced pluripotent stem cells from DMD patients would be a powerful tool for studying disease mechanisms.
机译:Duchenne肌营养不良症(DMD)是一种X连锁疾病,是由DMD基因突变引起的,该基因跨越Xp21位点的基因组序列的〜2.4?Mb。该突变导致蛋白质肌营养不良蛋白的损失。 DMD患者在第二个或第三个十年中因呼吸衰竭或心肌病而死亡,因为缺乏抗肌萎缩蛋白会导致肌纤维膜脆性和坏死,最终导致肌肉萎缩和挛缩。目前,尚无针对DMD的有效治疗方法,因此从DMD患者中诱导出的多能干细胞将成为研究疾病机制的有力工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号